Cunningham Everett has filed 27 insider transactions across 4 companies since June 2023.
Most recent transaction: a grant/award of 813750 shares of Quanterix Corp ($QTRX) on January 19, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 19, 2026 | Quanterix Corp | $QTRX | Cunningham Everett | President and CEO | A | Performance-Based Restricted Stock Units | 813750 | $0.00 | 813,750.0000 | 46,710,797 | 9999.99% | 1.74% |
| Jan. 19, 2026 | Quanterix Corp | $QTRX | Cunningham Everett | President and CEO | A | Time-Based Restricted Stock Units | 1070000 | $0.00 | 1,883,750.0000 | 46,710,797 | 131.49% | 2.29% |
| July 5, 2025 | ILLUMINA, INC. | $ILMN | Cunningham Everett | SVP, Chief Commercial Officer | F | Common Stock | 4248 | $97.15 | 46,592.0000 | 201,000,000 | 8.36% | 0.00% |
| June 25, 2025 | ARVINAS, INC. | $ARVN | Cunningham Everett | Director | A | Common Stock | 16025 | $0.00 | 26,045.0000 | 68,800,000 | 159.93% | 0.02% |
| June 25, 2025 | ARVINAS, INC. | $ARVN | Cunningham Everett | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| March 5, 2025 | ILLUMINA, INC. | $ILMN | Cunningham Everett | SVP, Chief Commercial Officer | A | Performance Shares | 10620 | $0.00 | 10,620.0000 | 200,000,000 | 9999.99% | 0.01% |
| March 5, 2025 | ILLUMINA, INC. | $ILMN | Cunningham Everett | SVP, Chief Commercial Officer | A | Performance Shares | 10620 | $0.00 | 10,620.0000 | 200,000,000 | 9999.99% | 0.01% |
| March 5, 2025 | ILLUMINA, INC. | $ILMN | Cunningham Everett | SVP, Chief Commercial Officer | A | Common Stock | 9103 | $0.00 | 50,840.0000 | 200,000,000 | 21.81% | 0.00% |
| July 5, 2024 | ILLUMINA, INC. | $ILMN | Cunningham Everett | SVP, Chief Commercial Officer | A | Performance Shares | 18430 | $0.00 | 18,430.0000 | 199,000,000 | 9999.99% | 0.01% |
| July 5, 2024 | ILLUMINA, INC. | $ILMN | Cunningham Everett | SVP, Chief Commercial Officer | A | Performance Shares | 18430 | $0.00 | 18,430.0000 | 199,000,000 | 9999.99% | 0.01% |
| July 5, 2024 | ILLUMINA, INC. | $ILMN | Cunningham Everett | SVP, Chief Commercial Officer | A | Common Stock | 36860 | $0.00 | 41,510.0000 | 199,000,000 | 792.69% | 0.02% |
| May 29, 2024 | ARVINAS, INC. | $ARVN | Cunningham Everett | Director | A | Common Stock | 5899 | $0.00 | 10,020.0000 | 68,000,000 | 143.14% | 0.01% |
| May 29, 2024 | ARVINAS, INC. | $ARVN | Cunningham Everett | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| April 30, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | A | Common Stock | 708 | $30.02 | 47,749.0000 | 0 | 1.51% | 0.00% |
| May 1, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | S | Common Stock | 136 | $60.15 | 47,613.0000 | 0 | 0.28% | 0.00% |
| April 30, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | A | Common Stock | 291 | $0.00 | 47,041.0000 | 0 | 0.62% | 0.00% |
| Feb. 29, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | M | Common Stock | 5291 | $0.00 | 49,162.0000 | 0 | 12.06% | 0.00% |
| March 1, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | S | Common Stock | 2412 | $59.32 | 46,750.0000 | 0 | 4.91% | 0.00% |
| Feb. 29, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | M | Restricted Stock Units | 5291 | $0.00 | 15,876.0000 | 0 | 25.00% | 0.00% |
| Feb. 26, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | M | Restricted Stock Units | 7678 | $0.00 | 15,356.0000 | 0 | 33.33% | 0.00% |
| Feb. 27, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | S | Common Stock | 3648 | $56.89 | 43,871.0000 | 0 | 7.68% | 0.00% |
| Feb. 26, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | M | Common Stock | 7678 | $0.00 | 47,519.0000 | 0 | 19.27% | 0.00% |
| Feb. 26, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | A | Restricted Stock Units | 31668 | $0.00 | 31,668.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | A | Common Stock | 2711 | $0.00 | 41,191.0000 | 0 | 7.05% | 0.00% |
| Feb. 22, 2024 | EXACT SCIENCES CORP | $EXAS | Cunningham Everett | Chief Commercial Officer | S | Common Stock | 1350 | $59.78 | 39,841.0000 | 0 | 3.28% | 0.00% |
| June 15, 2023 | ARVINAS, INC. | $ARVN | Cunningham Everett | Director | A | Common Stock | 4121 | $0.00 | 4,121.0000 | 53,200,000 | 9999.99% | 0.01% |
| June 15, 2023 | ARVINAS, INC. | $ARVN | Cunningham Everett | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |